로딩 중…
지수 로딩 중…
MapLight Therapeutics, Inc.
MPLT· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$28.82-1.34%
2026-06-18
Price Chart
MapLight Therapeutics, Inc.
Financials
No data
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $1.31B |
| Revenue | $0.00 |
| Net Income | $-199M |
| Total Assets | $419M |
| Net Assets | $400M |
| Value | |
| P/B | 3.27x |
| FCF Yield | -12.57% |
| Profitability | |
| ROE | -49.89% |
| ROA | -47.63% |
| Financial Health | |
| Debt Ratio | 4.74% |
| Total Debt | $6M |
| FCF | $-164M |
| Cash | $56M |
| Current Ratio | 22.91x |
| Performance | |
| 1M Return | 6.43% |
| From 52W High | -13.40% |
| 1Y MDD | -30.27% |
| Trading | |
| Volume | 980,818 shares |
| Trading Value | $29M |
| Per Share | |
| EPS | $-1.97 |
| BPS | $5.64 |